ENCORT TABLET 10MG [SIN17237P]
Active ingredients: ENCORT TABLET 10MG
Last updated 24 April 2026
Product Info
ENCORT TABLET 10MG
[SIN17237P]
Product information
Active Ingredient and Strength | HYDROCORTISONE - 10 MG |
Dosage Form | TABLET |
Manufacturer and Country | RENATA PLC - BANGLADESH |
Registration Number | SIN17237P |
Licence Holder | SEA PHARMA CONSULTANCY PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | H02AB09 |
Prescription-only Medicines with Exemptions for Supply without Prescription | NA |
Indication
Indications
Adrenocortical insufficiency (Addison’s disease), diminution of anterior pituitary function (hypopituitarism), congenital adrenal hyperplasia.
Conditions where systemic glucocorticoid therapy is indicated.
Dosing
Dosage and Administration
Adults:
For substitution therapy
20–30 mg/day, of which generally approx. 2/3 in the morning and 1/3 early in the evening. If necessary, the morning dose can be taken in two portions. For other indications, 40–200 mg/day, in short-term use for special indications even higher doses.
Children:
Dosage in children is individualised. In adrenocortical insufficiency, 7.5–15 mg/m2/day divided into three equal doses (immediately in the morning, in the afternoon, and late in the evening). The morning dose can also be higher than the other doses. In congenital adrenal hyperplasia, generally 10 mg/m2/day divided into three doses. In hypopituitarism, 2.5 mg three times daily.
For dosage in stress situations, See Special Warning/Precautions – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.
Contraindications
Contraindications
Tuberculosis and other acute or chronic bacterial and viral infections without antibiotic or chemotherapeutic protection, hypersensitivity to any ingredient of the preparation.